WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Helen Qi
Associate
Corporate
Palo Alto
hqi@wsgr.com

D650-849-3409

Download vCard
Open PDF

Helen Qi is a corporate and securities associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati. She works with private and public companies on general corporate and transactional matters, including mergers and acquisitions, corporate formation, and private and public offerings.

Prior to attending law school, Helen helped manage technology start-ups both in the San Francisco Bay Area and in China. Helen began her career in 2005 as an analyst, where she worked with hedge funds at the Blackstone Group in New York.

In addition to English, Helen is fluent in Mandarin Chinese.

Experience

Helen Qi is a corporate and securities associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati. She works with private and public companies on general corporate and transactional matters, including mergers and acquisitions, corporate formation, and private and public offerings.

Prior to attending law school, Helen helped manage technology start-ups both in the San Francisco Bay Area and in China. Helen began her career in 2005 as an analyst, where she worked with hedge funds at the Blackstone Group in New York.

In addition to English, Helen is fluent in Mandarin Chinese.

Education
  • J.D., UCLA School of Law, 2018
  • I.M.B.A., Tsinghua University-MIT Sloan, 2012Concentration in Cross-Border Transactions
  • B.S., Economics, The Wharton School of the University of Pennsylvania, 2004Concentration in Finance and Marketing
Admissions
  • State Bar of California
Credentials
Education
  • J.D., UCLA School of Law, 2018
  • I.M.B.A., Tsinghua University-MIT Sloan, 2012Concentration in Cross-Border Transactions
  • B.S., Economics, The Wharton School of the University of Pennsylvania, 2004Concentration in Finance and Marketing
Admissions
  • State Bar of California

Select Transactions

  • Represented Teachers' Venture Growth in its participation in Evolved By Nature's $120 million Series C fundraise
Matters

Select Transactions

  • Represented Teachers' Venture Growth in its participation in Evolved By Nature's $120 million Series C fundraise
Focus Areas
  • Capital Markets
  • Corporate
  • Corporate Governance
  • Emerging Companies and Venture Capital
  • Public Company Representation
Recent Insights
Client Highlights
Wilson Sonsini Advises Rhoda AI on $450 Million Funding as Company Emerges from Stealth
On March 10, 2026, Rhoda AI, a robotics intelligence start-up, announced it has emerged from stealth and raised $450 million in a Series A fundraising round led by Capricorn Investment Group, Khosla Ventures, Leitmotif, Matter Venture Partners, Mayfield, Premji Invest, Prelude Ventures, Temasek, Xora, and John Doerr, among others. Wilson Sonsini Goodrich & Rosati advised Rhoda AI on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Azalea Therapeutics on $82 Million Financing
On November 4, 2025, Azalea Therapeutics, a biotechnology company redefining precision genomic medicines in vivo, announced its official launch and completion of $82 million in seed and Series A financing to advance its proprietary Enveloped Delivery Vehicle (EDV) technology. The funding was led by Third Rock Ventures, with participation from RA Capital Management, Yosemite, Sozo Ventures, and select individual investors. Wilson Sonsini Goodrich & Rosati advised Azalea Therapeutics on the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.